Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colorectal Neoplasms | 13 | 2026 | 302 | 2.870 |
Why?
|
| Colectomy | 4 | 2025 | 35 | 0.990 |
Why?
|
| Poverty | 3 | 2026 | 233 | 0.930 |
Why?
|
| Ileus | 1 | 2023 | 14 | 0.820 |
Why?
|
| Colonic Neoplasms | 1 | 2023 | 162 | 0.730 |
Why?
|
| Abdominal Muscles | 1 | 2021 | 12 | 0.680 |
Why?
|
| Anesthesia, Conduction | 1 | 2021 | 15 | 0.680 |
Why?
|
| Neuromuscular Blockade | 1 | 2021 | 14 | 0.670 |
Why?
|
| Poverty Areas | 3 | 2026 | 52 | 0.660 |
Why?
|
| Colorectal Surgery | 3 | 2025 | 16 | 0.600 |
Why?
|
| Length of Stay | 2 | 2025 | 684 | 0.570 |
Why?
|
| Retrospective Studies | 10 | 2026 | 6819 | 0.450 |
Why?
|
| ABO Blood-Group System | 1 | 2012 | 16 | 0.390 |
Why?
|
| Registries | 3 | 2025 | 652 | 0.390 |
Why?
|
| Early Detection of Cancer | 3 | 2020 | 190 | 0.380 |
Why?
|
| Patient Readmission | 2 | 2024 | 251 | 0.360 |
Why?
|
| Laparoscopy | 2 | 2025 | 180 | 0.350 |
Why?
|
| Mass Screening | 3 | 2020 | 362 | 0.350 |
Why?
|
| Middle Aged | 15 | 2026 | 13419 | 0.350 |
Why?
|
| Male | 19 | 2026 | 27435 | 0.340 |
Why?
|
| Female | 20 | 2026 | 28782 | 0.340 |
Why?
|
| Quality Assurance, Health Care | 1 | 2011 | 146 | 0.330 |
Why?
|
| Aged | 12 | 2026 | 10429 | 0.330 |
Why?
|
| Arkansas | 4 | 2026 | 2068 | 0.320 |
Why?
|
| Insurance Coverage | 2 | 2024 | 124 | 0.320 |
Why?
|
| Tertiary Care Centers | 2 | 2025 | 86 | 0.280 |
Why?
|
| Humans | 22 | 2026 | 53230 | 0.280 |
Why?
|
| Healthcare Disparities | 2 | 2024 | 312 | 0.270 |
Why?
|
| Postoperative Complications | 2 | 2025 | 1099 | 0.260 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2020 | 98 | 0.250 |
Why?
|
| Rectal Diseases | 1 | 2025 | 12 | 0.240 |
Why?
|
| Povidone-Iodine | 1 | 2025 | 7 | 0.230 |
Why?
|
| Ghana | 4 | 2025 | 8 | 0.230 |
Why?
|
| Appendectomy | 1 | 2025 | 36 | 0.230 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2025 | 28 | 0.230 |
Why?
|
| Vitamin B Complex | 1 | 2024 | 22 | 0.220 |
Why?
|
| Choline | 1 | 2024 | 64 | 0.220 |
Why?
|
| Appendicitis | 1 | 2025 | 65 | 0.220 |
Why?
|
| Surgical Wound Infection | 1 | 2025 | 118 | 0.210 |
Why?
|
| Anastomotic Leak | 1 | 2023 | 11 | 0.210 |
Why?
|
| Venous Thromboembolism | 1 | 2025 | 78 | 0.210 |
Why?
|
| Adult | 9 | 2025 | 14534 | 0.210 |
Why?
|
| Intestinal Obstruction | 1 | 2023 | 38 | 0.200 |
Why?
|
| Neoplasm Staging | 4 | 2025 | 774 | 0.190 |
Why?
|
| Risk Factors | 3 | 2026 | 4017 | 0.190 |
Why?
|
| Health Status Disparities | 1 | 2025 | 221 | 0.190 |
Why?
|
| Anticoagulants | 1 | 2025 | 280 | 0.180 |
Why?
|
| Adenocarcinoma | 1 | 2025 | 405 | 0.180 |
Why?
|
| Case-Control Studies | 2 | 2024 | 1212 | 0.180 |
Why?
|
| Health Services Accessibility | 1 | 2026 | 477 | 0.170 |
Why?
|
| Pesticides | 1 | 2021 | 21 | 0.170 |
Why?
|
| Hospitals, Teaching | 1 | 2021 | 52 | 0.170 |
Why?
|
| Narcotics | 1 | 2021 | 108 | 0.160 |
Why?
|
| Survival Rate | 3 | 2025 | 949 | 0.160 |
Why?
|
| Ultrasonography, Mammary | 1 | 2020 | 61 | 0.160 |
Why?
|
| Diet | 1 | 2024 | 610 | 0.160 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2021 | 120 | 0.160 |
Why?
|
| Occupational Exposure | 1 | 2021 | 106 | 0.160 |
Why?
|
| Incidence | 3 | 2021 | 1085 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2025 | 487 | 0.140 |
Why?
|
| Sacrum | 1 | 2018 | 18 | 0.140 |
Why?
|
| Mandatory Programs | 1 | 2018 | 22 | 0.140 |
Why?
|
| Spinal Neoplasms | 1 | 2018 | 30 | 0.140 |
Why?
|
| Rural Population | 2 | 2025 | 596 | 0.140 |
Why?
|
| Orthopedic Procedures | 1 | 2018 | 71 | 0.130 |
Why?
|
| Lumbar Vertebrae | 1 | 2018 | 101 | 0.130 |
Why?
|
| Hospitalization | 1 | 2021 | 749 | 0.120 |
Why?
|
| Physicians | 1 | 2018 | 242 | 0.110 |
Why?
|
| Proportional Hazards Models | 2 | 2025 | 445 | 0.110 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2013 | 20 | 0.100 |
Why?
|
| Neoplasms | 1 | 2023 | 1334 | 0.100 |
Why?
|
| Fellowships and Scholarships | 2 | 2025 | 124 | 0.100 |
Why?
|
| Rectum | 1 | 2013 | 55 | 0.100 |
Why?
|
| Rectal Neoplasms | 1 | 2013 | 51 | 0.100 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2013 | 133 | 0.090 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 640 | 0.090 |
Why?
|
| Academic Medical Centers | 1 | 2012 | 153 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 1222 | 0.090 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 598 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 3494 | 0.060 |
Why?
|
| Hospitals, Urban | 1 | 2025 | 28 | 0.060 |
Why?
|
| Prognosis | 2 | 2025 | 2118 | 0.060 |
Why?
|
| Enoxaparin | 1 | 2025 | 32 | 0.060 |
Why?
|
| Random Allocation | 1 | 2025 | 284 | 0.050 |
Why?
|
| United States | 3 | 2023 | 5409 | 0.050 |
Why?
|
| Colonoscopy | 1 | 2024 | 107 | 0.050 |
Why?
|
| Urban Population | 1 | 2025 | 162 | 0.050 |
Why?
|
| Guideline Adherence | 1 | 2025 | 143 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2025 | 659 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2024 | 567 | 0.050 |
Why?
|
| Logistic Models | 1 | 2024 | 947 | 0.050 |
Why?
|
| Patient Selection | 1 | 2023 | 273 | 0.040 |
Why?
|
| Pesticide Residues | 1 | 2021 | 7 | 0.040 |
Why?
|
| Herbicides | 1 | 2021 | 11 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2024 | 742 | 0.040 |
Why?
|
| Democratic Republic of the Congo | 1 | 2020 | 4 | 0.040 |
Why?
|
| Research Design | 1 | 2023 | 373 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2024 | 479 | 0.040 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2020 | 34 | 0.040 |
Why?
|
| Image-Guided Biopsy | 1 | 2020 | 36 | 0.040 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2020 | 104 | 0.040 |
Why?
|
| Breast | 1 | 2020 | 87 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2024 | 1368 | 0.040 |
Why?
|
| Ultrasonography, Interventional | 1 | 2020 | 138 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2025 | 2411 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2020 | 411 | 0.040 |
Why?
|
| Occult Blood | 1 | 2017 | 23 | 0.030 |
Why?
|
| Morbidity | 1 | 2018 | 132 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 1038 | 0.030 |
Why?
|
| Rural Health | 1 | 2017 | 88 | 0.030 |
Why?
|
| Biopsy | 1 | 2018 | 600 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 623 | 0.030 |
Why?
|
| Young Adult | 1 | 2025 | 4511 | 0.030 |
Why?
|
| Adolescent | 1 | 2025 | 6907 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 2318 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 867 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 1219 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 5595 | 0.020 |
Why?
|